Abstract
The purpose of this study was to review the current status of risk factor assessment in Hodgkin's disease (HD) clinically useful for managing this disease. Regarding database retrieval and selection a literature search restricted to English-language articles, abstracts, book chapters and reports published between 1980 and 1993 was conducted both electronically using MEDLINE and CANCERLIT and manually using the bibliographies of the retrieved database. Out of approximately 500 publications identified for analysis, 34 were selected as illustrative. Results showed that most patients with Hodgkin's disease are curable at the outset with standard radio- or chemo-therapy, depending on stage and other risk factors. However, up to 40% of patients will either fail at initial induction, or experience early or late relapses. Risk factors analysis at these various times provide a solid base for selecting the therapy best suited to optimize outcome for each individual patient. Patients with truly refractory disease pose a serious challenge to clinicians and are best managed in specialized centers conducting controlled clinical trials. In conclusion it appears that although approximately 75% of newly diagnosed patients with HD can expect lon...Continue Reading
References
May 1, 1979·Annals of Internal Medicine·R I FisherR C Young
Sep 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U TirelliA Carbone
Sep 26, 1992·Journal of the National Cancer Institute·L B TravisJ F Fraumeni
Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D J StrausB D Clarkson
Jan 1, 1990·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S VivianiG Bonadonna
Feb 1, 1992·Annals of Internal Medicine·S C Gulati, C L Bennett
Mar 5, 1992·The New England Journal of Medicine·W J Urba, D L Longo
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N I Nissen, D Hovgaard
Feb 11, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Jun 15, 1991·Annals of Internal Medicine·A SurboneR P Gale
Dec 1, 1990·Cancer·C M MansfieldK Ayyangar
Mar 1, 1990·Cancer·F B HagemeisterT P Haynie
Apr 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L R ProsnitzE C Cadman
Sep 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M CarellaP Coser
Dec 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R E van RijswijkJ Verbeek
Dec 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H EkertD Mauger
Oct 1, 1988·Radiology·K D HopperJ Baumann
Sep 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Apr 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P RubinJ M Bennett
Dec 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A ListerP F Wrigley
Jul 1, 1993·Cancer·A AmbrosettiE Maggi
Citations
Apr 30, 1999·Leukemia & Lymphoma·D BenharrochJ Gopas
Sep 11, 2018·Nuclear Medicine Communications·Ismaheel O LawalMike M Sathekge
Jun 15, 2016·American Journal of Clinical Oncology·Kenneth B RobertsUNKNOWN Expert Panel on Radiation OncologyLymphoma